FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980453853> ?p ?o ?g. }

• W2980453853 endingPage "5" @default.
• W2980453853 startingPage "1" @default.
• W2980453853 abstract "We previously reported a case of giant cell carcinoma in the lung, in which the use of antiprogrammed death 1 (PD-1) immunotherapy resulted in substantial tumor reduction. In the present study, we describe an additional clinical course. A 69-year-old woman was diagnosed with giant cell carcinoma of the lung in clinical stage IVB (T2bN0M1c, BRA). The tumor expressed programmed death ligand 1 (PD-L1) in a high proportion. The patient received stereotactic radiotherapy for two sites of small brain metastases, followed by immunotherapy using anti-PD-1 antibodies (pembrolizumab). The treatment exerted a substantial tumor reduction through four cycles. However, treatment was withdrawn due to renal dysfunction. The primary lung tumor continued to regress for an additional four months without any further therapy, resulting in a clinical stage of T1aN0M0. Salvage thoracic surgery was then performed to remove the tumor residue in the lung. Microscopic examination of the sample revealed no residual cancer. The patient was free from recurrence at 16 months post surgery. We then comprehensively reviewed lung sarcomatoid carcinoma cases in the literature, in which anti-PD-1 antibodies were implemented. The current literature and our own findings suggest sarcomatoid carcinomas express high levels of tumoral PD-L1 and can be effectively treated with anti-PD-1 antibodies." @default.
• W2980453853 created "2019-10-25" @default.
• W2980453853 creator A5016564558 @default.
• W2980453853 creator A5035321464 @default.
• W2980453853 creator A5051997204 @default.
• W2980453853 creator A5072662904 @default.
• W2980453853 creator A5074910196 @default.
• W2980453853 creator A5081345866 @default.
• W2980453853 creator A5086077279 @default.
• W2980453853 creator A5091161390 @default.
• W2980453853 date "2019-10-15" @default.
• W2980453853 modified "2023-09-26" @default.
• W2980453853 title "A Histologically Complete Response to Immunotherapy Using Pembrolizumab in a Patient with Giant Cell Carcinoma of the Lung: An Additional Report and Literature Review" @default.
• W2980453853 cites W1205148714 @default.
• W2980453853 cites W1997733825 @default.
• W2980453853 cites W2030511761 @default.
• W2980453853 cites W2075710933 @default.
• W2980453853 cites W2087459740 @default.
• W2980453853 cites W2108034855 @default.
• W2980453853 cites W2141126466 @default.
• W2980453853 cites W2374218311 @default.
• W2980453853 cites W2397647271 @default.
• W2980453853 cites W2730279430 @default.
• W2980453853 cites W2743662849 @default.
• W2980453853 cites W2752059704 @default.
• W2980453853 cites W2766033739 @default.
• W2980453853 cites W2770629979 @default.
• W2980453853 cites W2789227594 @default.
• W2980453853 cites W2790902230 @default.
• W2980453853 cites W2793368960 @default.
• W2980453853 cites W2804057435 @default.
• W2980453853 cites W2890566493 @default.
• W2980453853 cites W2895608724 @default.
• W2980453853 cites W2896140991 @default.
• W2980453853 cites W2904811331 @default.
• W2980453853 cites W2943557359 @default.
• W2980453853 doi "https://doi.org/10.1155/2019/1763625" @default.
• W2980453853 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6815550" @default.
• W2980453853 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31737389" @default.
• W2980453853 hasPublicationYear "2019" @default.
• W2980453853 type Work @default.
• W2980453853 sameAs 2980453853 @default.
• W2980453853 citedByCount "3" @default.
• W2980453853 countsByYear W29804538532022 @default.
• W2980453853 countsByYear W29804538532023 @default.
• W2980453853 crossrefType "journal-article" @default.
• W2980453853 hasAuthorship W2980453853A5016564558 @default.
• W2980453853 hasAuthorship W2980453853A5035321464 @default.
• W2980453853 hasAuthorship W2980453853A5051997204 @default.
• W2980453853 hasAuthorship W2980453853A5072662904 @default.
• W2980453853 hasAuthorship W2980453853A5074910196 @default.
• W2980453853 hasAuthorship W2980453853A5081345866 @default.
• W2980453853 hasAuthorship W2980453853A5086077279 @default.
• W2980453853 hasAuthorship W2980453853A5091161390 @default.
• W2980453853 hasBestOaLocation W29804538531 @default.
• W2980453853 hasConcept C121608353 @default.
• W2980453853 hasConcept C126322002 @default.
• W2980453853 hasConcept C126838900 @default.
• W2980453853 hasConcept C141071460 @default.
• W2980453853 hasConcept C142724271 @default.
• W2980453853 hasConcept C143998085 @default.
• W2980453853 hasConcept C146357865 @default.
• W2980453853 hasConcept C151730666 @default.
• W2980453853 hasConcept C2776256026 @default.
• W2980453853 hasConcept C2777546739 @default.
• W2980453853 hasConcept C2777701055 @default.
• W2980453853 hasConcept C2777714996 @default.
• W2980453853 hasConcept C2779327097 @default.
• W2980453853 hasConcept C2780057760 @default.
• W2980453853 hasConcept C509974204 @default.
• W2980453853 hasConcept C71924100 @default.
• W2980453853 hasConcept C86803240 @default.
• W2980453853 hasConceptScore W2980453853C121608353 @default.
• W2980453853 hasConceptScore W2980453853C126322002 @default.
• W2980453853 hasConceptScore W2980453853C126838900 @default.
• W2980453853 hasConceptScore W2980453853C141071460 @default.
• W2980453853 hasConceptScore W2980453853C142724271 @default.
• W2980453853 hasConceptScore W2980453853C143998085 @default.
• W2980453853 hasConceptScore W2980453853C146357865 @default.
• W2980453853 hasConceptScore W2980453853C151730666 @default.
• W2980453853 hasConceptScore W2980453853C2776256026 @default.
• W2980453853 hasConceptScore W2980453853C2777546739 @default.
• W2980453853 hasConceptScore W2980453853C2777701055 @default.
• W2980453853 hasConceptScore W2980453853C2777714996 @default.
• W2980453853 hasConceptScore W2980453853C2779327097 @default.
• W2980453853 hasConceptScore W2980453853C2780057760 @default.
• W2980453853 hasConceptScore W2980453853C509974204 @default.
• W2980453853 hasConceptScore W2980453853C71924100 @default.
• W2980453853 hasConceptScore W2980453853C86803240 @default.
• W2980453853 hasLocation W29804538531 @default.
• W2980453853 hasLocation W29804538532 @default.
• W2980453853 hasLocation W29804538533 @default.
• W2980453853 hasLocation W29804538534 @default.
• W2980453853 hasLocation W29804538535 @default.
• W2980453853 hasOpenAccess W2980453853 @default.
• W2980453853 hasPrimaryLocation W29804538531 @default.
• W2980453853 hasRelatedWork W1994154739 @default.
• W2980453853 hasRelatedWork W2767114511 @default.

• next